Hub : Traits :

Suffer from 'nerves'

210 significantly associated models · 45 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 2 199443880 201021954 1 1 8.9e-08 2.0e-09 3.8e-03 77 SATB2
2 3 84317575 86808226 1 1 3.7e-11 1.1e-11 1.1e-03 77 CADM2
3 8 8092025 11748645 10 1 2.2e-11 5.1e-10 1.3e-01 94 AF131215.2
4 8 118508942 120333035 1 1 3.5e-07 2.6e-04 9.0e-04 17 SAMD12
5 10 92472343 93964017 1 1 3.4e-07 7.9e-07 1.0e+00 100 HECTD2
6 11 46578400 48559571 12 8 1.7e-16 4.6e-16 1.0e+00 100 C1QTNF4 MADD MTCH2 MYBPC3 NR1H3
7 11 112486568 113940469 1 1 8.7e-08 3.1e-07 5.8e-01 99 TTC12
8 14 74658029 76064624 1 1 1.4e-07 3.7e-08 1.0e-01 91 DLST
9 16 27687385 29595483 15 1 3.7e-09 1.1e-08 8.3e-02 91 SH2B1
10 18 57349900 58729694 1 1 2.2e-08 9.4e-12 8.0e-06 57 MC4R
11 20 17870542 19441650 1 1 6.4e-08 5.6e-08 1.0e+00 100 DTD1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (including proxy) 4.27 3 0 0.0 -0.98 1.6e-02 C1QTNF4 MADD MTCH2
Crohns Disease (2017) 1.93 1 1 3.0 0.00 1.0e+00 SH2B1
Irritable Bowel Disease (IBD) 2.68 2 2 6.1 0.00 1.0e+00 SATB2 SH2B1
Ulcerative Colitis (UC) 2.93 3 1 3.0 0.00 1.0e+00 CADM2 SATB2 SH2B1
Verbal and Numeric Reasoning (VNR) 6.17 6 4 12.1 -0.69 5.6e-02 C1QTNF4 MADD MTCH2 MYBPC3 NR1H3 SH2B1
Breast Cancer 1.08 1 0 0.0 0.00 1.0e+00 MADD
Age at First Birth 1.03 1 0 0.0 0.00 1.0e+00 DTD1
Body Mass Index (BMI) (2010) 10.53 6 3 9.1 0.99 2.7e-06 C1QTNF4 MADD MC4R MTCH2 MYBPC3 NR1H3
Mean Putamen Volume 2.17 1 0 0.0 0.00 1.0e+00 SAMD12
Fasting Glucose 4.63 1 1 3.0 0.00 1.0e+00 MADD
HDL Cholesterol 9.68 5 5 15.2 -0.97 1.6e-03 C1QTNF4 MADD MTCH2 MYBPC3 NR1H3
Lupus 1.97 1 0 0.0 0.00 1.0e+00 AF131215.2
Neuroticism 8.82 6 1 3.0 -0.95 4.2e-03 AF131215.2 C1QTNF4 DLST MADD MTCH2 MYBPC3
Triglycerides 2.01 1 0 0.0 0.00 1.0e+00 AF131215.2
Type 2 Diabetes (T2D) 2.10 1 0 0.0 0.00 1.0e+00 MC4R
Ulcerative Colitis 1.91 1 0 0.0 0.00 1.0e+00 SATB2
Blood Eosinophil Count 0.63 2 0 0.0 0.00 1.0e+00 MADD MTCH2
Blood Platelet Count 2.68 6 6 18.2 -0.86 5.8e-03 C1QTNF4 DLST MADD MTCH2 MYBPC3 NR1H3
Blood Red Count 1.04 4 1 3.0 0.89 1.1e-01 C1QTNF4 MTCH2 MYBPC3 SH2B1
Blood White Count 4.15 6 4 12.1 0.87 4.9e-03 C1QTNF4 MADD MTCH2 MYBPC3 NR1H3 TTC12
Heel T-Score 1.65 5 2 6.1 0.57 2.4e-01 DLST DTD1 MADD NR1H3 SATB2
BMI 11.59 9 8 24.2 0.72 8.0e-03 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Height 3.27 8 7 21.2 -0.83 3.2e-03 C1QTNF4 HECTD2 MADD MC4R MTCH2 MYBPC3 NR1H3 SAMD12
Waist Hip Ratio (WHR) 0.67 1 0 0.0 0.00 1.0e+00 TTC12
Systolic Blood Pressure 4.26 5 5 15.2 -0.96 4.9e-04 C1QTNF4 CADM2 MADD MTCH2 MYBPC3
Smoking Status 3.09 4 1 3.0 -0.45 5.5e-01 C1QTNF4 CADM2 MTCH2 MYBPC3
Allergy or Eczema 1.05 1 0 0.0 0.00 1.0e+00 SH2B1
Cardiovascular Disease 1.86 2 0 0.0 0.00 1.0e+00 MADD TTC12
Hypothyroidism (self reported) 3.11 3 0 0.0 0.00 1.0e+00 C1QTNF4 MADD MYBPC3
Type 2 Diabetes (T2D) 2.68 1 0 0.0 0.00 1.0e+00 C1QTNF4
Lung FEV1/FVC ratio 0.72 1 1 3.0 0.00 1.0e+00 DLST
Lung FVC 1.09 2 0 0.0 0.00 1.0e+00 SATB2 SH2B1
Neuroticism 8.98 10 6 18.2 -0.97 2.9e-07 C1QTNF4 CADM2 DLST DTD1 MADD MC4R MTCH2 MYBPC3 NR1H3 TTC12
Chronotype (morning person) 3.51 4 2 6.1 0.74 2.6e-01 C1QTNF4 HECTD2 MADD NR1H3
Hair Pigment 0.22 2 1 3.0 0.00 1.0e+00 C1QTNF4 MADD
Tanning 0.62 3 1 3.0 0.00 1.0e+00 C1QTNF4 CADM2 MYBPC3
Hand grip strength (left) 5.10 5 3 9.1 0.81 4.9e-02 C1QTNF4 CADM2 MADD MTCH2 MYBPC3
Number of treatments/medications taken 2.54 2 1 3.0 0.00 1.0e+00 DLST TTC12
Average weekly spirits intake 1.55 1 0 0.0 0.00 1.0e+00 SAMD12
Sensitivity / hurt feelings 3.16 2 1 3.0 0.00 1.0e+00 AF131215.2 TTC12
Frequency of depressed mood in last 2 weeks 5.29 3 0 0.0 0.00 1.0e+00 C1QTNF4 MADD MTCH2
Hearing difficulty/problems: Yes 1.01 1 0 0.0 0.00 1.0e+00 SATB2
Relative age of first facial hair 1.46 1 0 0.0 0.00 1.0e+00 SATB2
Other serious medical condition/disability diagnosed by doctor 1.44 1 0 0.0 0.00 1.0e+00 TTC12
Ever used hormone-replacement therapy (HRT) 3.40 1 0 0.0 0.00 1.0e+00 MTCH2
Systolic blood pressure, automated reading 2.19 3 1 3.0 0.00 1.0e+00 AF131215.2 C1QTNF4 MADD
Eye problems/disorders: Diabetes related eye disease 4.75 2 0 0.0 0.00 1.0e+00 C1QTNF4 MADD
Medication: Metformin 4.59 2 0 0.0 0.00 1.0e+00 C1QTNF4 MADD
Pack years adult smoking proportion 1.98 1 0 0.0 0.00 1.0e+00 SH2B1
Impedance of leg (right) 5.58 8 6 18.2 0.80 3.4e-03 AF131215.2 C1QTNF4 CADM2 MADD MC4R NR1H3 SATB2 SH2B1
Leg fat-free mass (left) 4.50 6 5 15.2 -0.67 9.8e-02 AF131215.2 CADM2 MADD MC4R NR1H3 SH2B1
Trunk fat percentage 11.90 8 7 21.2 -0.62 4.1e-02 C1QTNF4 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Hand grip strength (right) 3.77 5 2 6.1 0.75 8.6e-02 C1QTNF4 MADD MTCH2 MYBPC3 SH2B1
Townsend deprivation index at recruitment 3.48 2 0 0.0 0.00 1.0e+00 MTCH2 MYBPC3
Current tobacco smoking 4.72 3 0 0.0 0.99 8.0e-03 C1QTNF4 MTCH2 MYBPC3
Fed-up feelings 5.09 5 2 6.1 0.93 2.0e-02 AF131215.2 DLST MADD SH2B1 TTC12
Frequency of unenthusiasm / disinterest in last 2 weeks 3.97 2 0 0.0 0.00 1.0e+00 MADD TTC12
Relative age voice broke 1.42 1 0 0.0 0.00 1.0e+00 SATB2
Taking other prescription medications 3.02 1 0 0.0 0.00 1.0e+00 DLST
Age when periods started (menarche) 7.96 5 5 15.2 0.95 3.0e-04 C1QTNF4 MADD MTCH2 NR1H3 SATB2
Heel bone mineral density (BMD) T-score, automated (left) 3.40 1 1 3.0 0.00 1.0e+00 AF131215.2
High blood pressure 3.36 2 2 6.1 0.27 7.3e-01 AF131215.2 MADD
Sitting height 3.91 5 5 15.2 0.98 8.8e-05 C1QTNF4 HECTD2 MADD MTCH2 MYBPC3
Body mass index (BMI) 11.43 10 9 27.3 -0.81 6.9e-04 AF131215.2 C1QTNF4 CADM2 HECTD2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1
Impedance of leg (left) 5.24 8 6 18.2 0.81 4.8e-03 AF131215.2 C1QTNF4 CADM2 DLST MADD MC4R NR1H3 SH2B1
Leg predicted mass (left) 4.55 6 5 15.2 -0.67 9.8e-02 AF131215.2 CADM2 MADD MC4R NR1H3 SH2B1
Trunk fat mass 9.46 9 7 21.2 -0.60 3.9e-02 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Waist circumference 8.52 9 7 21.2 -0.57 5.3e-02 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Past tobacco smoking 2.75 2 1 3.0 0.00 1.0e+00 CADM2 DLST
Alcohol usually taken with meals 1.83 1 0 0.0 0.00 1.0e+00 SH2B1
Nervous feelings 11.07 9 3 9.1 0.95 3.7e-05 AF131215.2 C1QTNF4 CADM2 DLST DTD1 MADD MTCH2 SATB2 TTC12
Frequency of tenseness / restlessness in last 2 weeks 4.84 3 0 0.0 0.00 1.0e+00 C1QTNF4 MADD MTCH2
Forced vital capacity (FVC) 3.39 5 4 12.1 1.00 2.6e-05 C1QTNF4 MADD MTCH2 MYBPC3 SATB2
Heel bone mineral density (BMD) T-score, automated (right) 3.34 1 1 3.0 0.00 1.0e+00 AF131215.2
Qualifications: None of the above 1.56 1 1 3.0 0.00 1.0e+00 SH2B1
Fluid intelligence score 6.08 6 3 9.1 0.71 4.9e-02 C1QTNF4 MADD MTCH2 MYBPC3 NR1H3 SH2B1
Neuroticism score 11.88 10 6 18.2 0.96 7.6e-07 AF131215.2 C1QTNF4 CADM2 DLST DTD1 MADD MC4R MTCH2 MYBPC3 TTC12
Weight 5.80 8 6 18.2 -0.51 1.1e-01 AF131215.2 C1QTNF4 CADM2 MADD MC4R NR1H3 SH2B1 TTC12
Impedance of arm (right) 3.13 4 3 9.1 0.98 2.1e-02 AF131215.2 CADM2 MC4R SATB2
Arm fat percentage (right) 14.87 10 8 24.2 -0.69 8.7e-03 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Trunk fat-free mass 3.69 7 5 15.2 0.09 8.3e-01 AF131215.2 C1QTNF4 CADM2 MC4R MTCH2 MYBPC3 SH2B1
Hip circumference 7.85 10 7 21.2 -0.59 3.3e-02 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Father's age at death 1.73 1 0 0.0 0.00 1.0e+00 AF131215.2
Worrier / anxious feelings 9.10 6 3 9.1 0.97 1.3e-03 AF131215.2 CADM2 DLST DTD1 MC4R SATB2
Frequency of tiredness / lethargy in last 2 weeks 3.94 2 0 0.0 0.00 1.0e+00 C1QTNF4 MTCH2
Forced expiratory volume in 1-second (FEV1) 2.71 6 0 0.0 1.00 2.6e-07 AF131215.2 C1QTNF4 MADD MTCH2 MYBPC3 SATB2
Happiness 1.78 1 0 0.0 0.00 1.0e+00 DLST
Qualifications: A levels/AS levels or equivalent 1.18 1 0 0.0 0.00 1.0e+00 SH2B1
Serious illness, injury or assault of a close relative in last 2 years 2.37 1 0 0.0 0.00 1.0e+00 SH2B1
Mouth/teeth dental problems: Dentures 1.27 1 0 0.0 0.00 1.0e+00 AF131215.2
Forced expiratory volume in 1-second (FEV1), Best measure 3.35 6 2 6.1 0.99 1.4e-05 AF131215.2 C1QTNF4 MADD MTCH2 MYBPC3 SATB2
Impedance of arm (left) 3.30 4 3 9.1 0.98 2.2e-02 AF131215.2 CADM2 MC4R SATB2
Arm fat mass (right) 11.19 10 9 27.3 -0.67 1.2e-02 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Trunk predicted mass 3.65 7 5 15.2 0.08 8.4e-01 AF131215.2 C1QTNF4 CADM2 MC4R MTCH2 MYBPC3 SH2B1
Standing height 4.31 10 6 18.2 0.83 8.2e-04 AF131215.2 C1QTNF4 HECTD2 MADD MC4R MTCH2 MYBPC3 NR1H3 SAMD12 SH2B1
Breastfed as a baby 3.74 1 0 0.0 0.00 1.0e+00 MTCH2
Tense / 'highly strung' 6.82 5 2 6.1 0.96 1.1e-02 AF131215.2 CADM2 DTD1 MADD TTC12
Seen doctor (GP) for nerves, anxiety, tension or depression 4.94 3 0 0.0 0.00 1.0e+00 MTCH2 MYBPC3 TTC12
Birth weight of first child 1.18 1 0 0.0 0.00 1.0e+00 SH2B1
Peak expiratory flow (PEF) 2.26 3 0 0.0 0.00 1.0e+00 AF131215.2 C1QTNF4 MTCH2
Hypothyroidism/myxoedema (self-reported) 2.56 1 0 0.0 0.00 1.0e+00 AF131215.2
Birth weight 3.26 3 0 0.0 0.00 1.0e+00 C1QTNF4 MADD MTCH2
Forced vital capacity (FVC), Best measure 4.23 5 4 12.1 0.99 1.7e-04 C1QTNF4 MADD MTCH2 MYBPC3 SATB2
Body fat percentage 12.02 8 7 21.2 -0.64 3.5e-02 C1QTNF4 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Leg fat percentage (right) 8.99 11 7 21.2 -0.65 1.7e-02 AF131215.2 C1QTNF4 CADM2 DLST MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Arm fat-free mass (right) 3.45 5 4 12.1 -0.69 2.0e-01 AF131215.2 CADM2 MC4R MTCH2 SH2B1
Comparative body size at age 10 13.68 9 9 27.3 -0.83 8.3e-04 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1
Worry too long after embarrassment 4.70 2 2 6.1 0.00 1.0e+00 AF131215.2 TTC12
Number of children fathered 2.30 1 0 0.0 0.00 1.0e+00 CADM2
Age at first live birth 1.99 1 0 0.0 0.00 1.0e+00 AF131215.2
Qualifications: College or University degree 1.40 1 1 3.0 0.00 1.0e+00 SH2B1
Medication for pain relief, constipation, heartburn 1.54 1 0 0.0 0.00 1.0e+00 DLST
Medication: Blood pressure 2.10 1 0 0.0 0.00 1.0e+00 AF131215.2
Whole body fat mass 9.69 10 7 21.2 -0.64 2.0e-02 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Leg fat mass (right) 8.98 10 9 27.3 -0.66 1.3e-02 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Arm predicted mass (right) 3.24 5 4 12.1 -0.68 2.0e-01 AF131215.2 CADM2 MC4R MTCH2 SH2B1
Alcohol intake frequency. 7.96 7 5 15.2 -0.32 4.3e-01 C1QTNF4 CADM2 MADD MTCH2 MYBPC3 SAMD12 SH2B1
Comparative height size at age 10 2.91 8 4 12.1 0.83 5.9e-03 C1QTNF4 DLST HECTD2 MADD MTCH2 MYBPC3 SH2B1 TTC12
Number of full sisters 1.47 1 0 0.0 0.00 1.0e+00 CADM2
Overall health rating 2.03 2 1 3.0 0.00 1.0e+00 AF131215.2 TTC12
Age at last live birth 3.03 3 0 0.0 0.00 1.0e+00 AF131215.2 CADM2 DTD1
Knee pain experienced in last month 3.28 1 0 0.0 0.00 1.0e+00 MADD
Hypertension (Self-reported) 3.15 2 1 3.0 0.27 7.3e-01 AF131215.2 MADD
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported) 3.82 1 0 0.0 0.00 1.0e+00 DLST
Smoking status: Previous 2.27 1 1 3.0 0.00 1.0e+00 CADM2
Forced expiratory volume in 1-second (FEV1), predicted 3.73 4 0 0.0 0.99 9.8e-04 C1QTNF4 MADD MTCH2 MYBPC3
Whole body fat-free mass 3.50 6 4 12.1 -0.67 1.5e-01 AF131215.2 CADM2 MADD MC4R MTCH2 SH2B1
Leg fat-free mass (right) 4.39 6 5 15.2 -0.68 9.0e-02 AF131215.2 CADM2 MADD MC4R NR1H3 SH2B1
Arm fat percentage (left) 15.78 9 8 24.2 -0.70 1.2e-02 AF131215.2 C1QTNF4 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Average weekly red wine intake 2.20 1 0 0.0 0.00 1.0e+00 CADM2
Handedness (chirality/laterality): Left-handed 1.69 1 0 0.0 0.00 1.0e+00 SH2B1
Mood swings 7.79 6 3 9.1 0.97 2.3e-04 AF131215.2 C1QTNF4 DLST MADD MTCH2 TTC12
Loneliness, isolation 9.08 5 3 9.1 1.00 2.9e-05 C1QTNF4 MADD MTCH2 MYBPC3 NR1H3
Long-standing illness, disability or infirmity 1.89 1 0 0.0 0.00 1.0e+00 TTC12
Mouth/teeth dental problems: Mouth ulcers 1.17 1 0 0.0 0.00 1.0e+00 CADM2
Smoking status: Current 4.93 3 0 0.0 0.99 9.6e-03 C1QTNF4 MTCH2 MYBPC3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.31 2 0 0.0 0.00 1.0e+00 AF131215.2 SH2B1
Whole body water mass 3.50 6 4 12.1 -0.66 1.5e-01 AF131215.2 CADM2 MADD MC4R MTCH2 SH2B1
Leg predicted mass (right) 4.38 6 5 15.2 -0.68 9.0e-02 AF131215.2 CADM2 MADD MC4R NR1H3 SH2B1
Arm fat mass (left) 11.31 10 9 27.3 -0.68 1.1e-02 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Miserableness 9.00 5 4 12.1 0.99 2.1e-04 AF131215.2 C1QTNF4 MADD MTCH2 TTC12
Guilty feelings 6.08 5 3 9.1 0.97 6.3e-03 AF131215.2 C1QTNF4 DLST MADD TTC12
Medication: Blood pressure 2.48 1 1 3.0 0.00 1.0e+00 AF131215.2
Medication: Bendroflumethiazide 2.68 2 0 0.0 0.00 1.0e+00 AF131215.2 MADD
Medication: Paracetamol 1.68 1 0 0.0 0.00 1.0e+00 SH2B1
Illnesses of father: High blood pressure 2.45 1 0 0.0 0.00 1.0e+00 MADD
Alcohol drinker status: Never 4.27 1 0 0.0 0.00 1.0e+00 C1QTNF4
Ever smoked 3.10 2 1 3.0 0.00 1.0e+00 CADM2 DLST
Basal metabolic rate 3.73 5 4 12.1 -0.74 1.5e-01 AF131215.2 CADM2 MADD MC4R SH2B1
Leg fat percentage (left) 9.90 11 7 21.2 -0.66 1.4e-02 AF131215.2 C1QTNF4 CADM2 DLST MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Arm fat-free mass (left) 3.53 5 4 12.1 -0.68 2.0e-01 AF131215.2 CADM2 MC4R MTCH2 SH2B1
Average weekly beer plus cider intake 3.96 1 0 0.0 0.00 1.0e+00 MYBPC3
Irritability 4.49 1 1 3.0 0.00 1.0e+00 AF131215.2
Risk taking 4.11 2 1 3.0 0.00 1.0e+00 AF131215.2 CADM2
Diastolic blood pressure, automated reading 2.27 2 1 3.0 0.00 1.0e+00 AF131215.2 MADD
Myopia 4.14 4 0 0.0 0.98 2.4e-02 C1QTNF4 MADD MTCH2 MYBPC3
Vascular/heart problems diagnosed by doctor 2.79 2 1 3.0 -0.29 7.1e-01 AF131215.2 MADD
Medication: Omeprazole (e.g. Zanprol) 1.73 1 0 0.0 0.00 1.0e+00 SATB2
Pack years of smoking 1.61 1 0 0.0 0.00 1.0e+00 SH2B1
Impedance of whole body 3.71 4 3 9.1 0.96 3.6e-02 AF131215.2 CADM2 MC4R SATB2
Leg fat mass (left) 9.32 10 9 27.3 -0.67 1.2e-02 AF131215.2 C1QTNF4 CADM2 MADD MC4R MTCH2 MYBPC3 NR1H3 SH2B1 TTC12
Arm predicted mass (left) 3.48 5 4 12.1 -0.67 2.1e-01 AF131215.2 CADM2 MC4R MTCH2 SH2B1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 4 0.1146 1.58
GTEx Adipose Visceral Omentum 4 0.1965 1.66
GTEx Adrenal Gland 4 0.2745 1.59
GTEx Artery Aorta 7 0.2351 1.64
GTEx Artery Coronary 2 0.1691 1.67
GTEx Artery Tibial 7 0.1861 1.58
GTEx Brain Caudate basal ganglia 0 0.0000 1.62
GTEx Brain Cerebellar Hemisphere 3 0.2015 1.58
GTEx Brain Cerebellum 3 0.1514 1.52
GTEx Brain Cortex 3 0.2899 1.79
GTEx Brain Frontal Cortex BA9 2 0.2165 1.70
GTEx Brain Hippocampus 0 0.0000 1.75
GTEx Brain Hypothalamus 1 0.1695 1.70
GTEx Brain Nucleus accumbens basal ganglia 0 0.0000 1.60
GTEx Brain Putamen basal ganglia 0 0.0000 1.67
GTEx Breast Mammary Tissue 8 0.4053 1.68
GTEx Breast Mammary Tissue (Male) 1 0.0838 1.56
GTEx Breast Mammary Tissue (Female) 6 0.3650 1.70
GTEx Cells EBV-transformed lymphocytes 1 0.0703 1.64
GTEx Cells Transformed fibroblasts 10 0.2382 1.57
GTEx Colon Sigmoid 5 0.3420 1.67
GTEx Colon Transverse 6 0.2907 1.74
GTEx Esophagus Gastroesophageal Junction 2 0.1384 1.64
GTEx Esophagus Mucosa 9 0.2711 1.60
GTEx Esophagus Muscularis 8 0.2475 1.67
GTEx Heart Atrial Appendage 1 0.0633 1.69
GTEx Heart Left Ventricle 6 0.3922 1.63
GTEx Liver 1 0.1395 1.96
GTEx Lung 5 0.1740 1.63
GTEx Muscle Skeletal 7 0.2422 1.67
GTEx Nerve Tibial 6 0.1389 1.58
GTEx Ovary 5 0.5507 1.82
GTEx Pancreas 3 0.1838 1.63
GTEx Pituitary 3 0.2691 1.68
GTEx Prostate 2 0.2395 1.68
GTEx Skin Not Sun Exposed Suprapubic 7 0.2847 1.72
GTEx Skin Sun Exposed Lower leg 8 0.2198 1.64
GTEx Small Intestine Terminal Ileum 0 0.0000 1.85
GTEx Spleen 5 0.3544 1.71
GTEx Stomach 4 0.2751 1.70
GTEx Testis 5 0.1585 1.62
GTEx Thyroid 5 0.1250 1.55
GTEx Uterus 2 0.3527 1.73
GTEx Vagina 3 0.4724 1.70
GTEx Whole Blood 4 0.2007 1.68
METSIM Adipose 4 0.0868 1.52
NTR Blood 2 0.0833 1.60
ROSMAP Brain Pre-frontal Cortex 8 0.1822 1.66
YFS Blood 4 0.0866 1.48
CommonMind Brain Pre-frontal Cortex 7 0.1302 1.54
TCGA Breast Tumor 0 0.0000 1.59
TCGA Breast Normal 1 0.0238 1.37
TCGA Ovarian Tumor 3 0.1027 1.46
TCGA Prostate Tumor 3 0.0867 1.47